| 1 | International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP) | Pharmacotherapy | 2019 | 775 |
| 2 | Plasma and Tissue Protein Binding of Drugs in Pharmacokinetics | Drug Metabolism Reviews | 1976 | 387 |
| 3 | Per Cent Absorbed Time Plots Derived from Blood Level and/or Urinary Excretion Data | Journal of Pharmaceutical Sciences | 1963 | 361 |
| 4 | Physiologic indirect response models characterize diverse types of pharmacodynamic effects | Clinical Pharmacology and Therapeutics | 1994 | 340 |
| 5 | Pharmacologic target-mediated drug disposition | Clinical Pharmacology and Therapeutics | 1994 | 313 |
| 6 | Effects of aluminum and magnesium antacids and ranitidine on the absorption of ciprofloxacin | Clinical Pharmacology and Therapeutics | 1989 | 212 |
| 7 | Cloning, localization, and permanent expression of a Drosophila octopamine receptor | Neuron | 1990 | 197 |
| 8 | Inpatient costs, mortality and 30-day re-admission in patients with central-line-associated bloodstream infections | Clinical Microbiology and Infection | 2014 | 159 |
| 9 | Reduction in endotoxemia, oxidative and inflammatory stress, and insulin resistance after Roux-en-Y gastric bypass surgery in patients with morbid obesity and type 2 diabetes mellitus | Surgery | 2012 | 136 |
| 10 | Effect of Plasma Protein Binding on Elimination of Warfarin | Journal of Pharmaceutical Sciences | 1974 | 126 |
| 11 | Opioid Therapy in Acute and Chronic Pain | Journal of Clinical Pharmacology | 2018 | 116 |
| 12 | Population pharmacokinetics of sirolimus in kidney transplant patients* | Clinical Pharmacology and Therapeutics | 1997 | 106 |
| 13 | Antibiotic dosing issues in lower respiratory tract infection: population-derived area under inhibitory curve is predictive of efficacy | Journal of Antimicrobial Chemotherapy | 1999 | 106 |
| 14 | Clinical Pharmacokinetics of Non-Nucleoside Reverse Transcriptase Inhibitors | Clinical Pharmacokinetics | 2012 | 106 |
| 15 | Efficacy and Safety of Vamorolone vs Placebo and Prednisone Among Boys With Duchenne Muscular Dystrophy | JAMA Neurology | 2022 | 104 |
| 16 | Sucralfate reduces the gastrointestinal absorption of norfloxacin | Antimicrobial Agents and Chemotherapy | 1989 | 102 |
| 17 | Active metabolites of imipramine and desipramine in man | Clinical Pharmacology and Therapeutics | 1982 | 92 |
| 18 | Impact of Rapid Methicillin-Resistant Staphylococcus aureus Polymerase Chain Reaction Testing on Mortality and Cost Effectiveness in Hospitalized Patients with Bacteraemia | Pharmacoeconomics | 2012 | 89 |
| 19 | Mechanism-based pharmacodynamic modeling | Clinical Pharmacology and Therapeutics | 1994 | 88 |
| 20 | Single housing‐induced effects on cognitive impairment and depression‐like behavior in male and female mice involve neuroplasticity‐related signaling | European Journal of Neuroscience | 2020 | 88 |
| 21 | Antimicrobial Action and Pharmacokinetics/Pharmacodynamics: The Use of AUIC to Improve Efficacy and Avoid Resistance | Journal of Chemotherapy | 1999 | 87 |
| 22 | Pharmacokinetics and pharmacodynamic modeling of direct suppression effects of methylprednisolone on serum cortisol and blood histamine in human subjects | Clinical Pharmacology and Therapeutics | 1989 | 81 |
| 23 | Clinical Pharmacology of the Fluoroquinolones: Studies in Human Dynamic/Kinetic Models | Clinical Infectious Diseases | 2000 | 81 |
| 24 | Consensus Summary of Aerosolized Antimicrobial Agents: Application of Guideline Criteria | Pharmacotherapy | 2010 | 79 |
| 25 | Pharmacokinetics and Pharmacodynamics of Intramuscular and Oral Betamethasone and Dexamethasone in Reproductive Age Women in India | Clinical and Translational Science | 2020 | 76 |
| 26 | Serum concentration and renal excretion by normal adults of inorganic sulfate after acetaminophen, ascorbic acid, or sodium sulfate | Clinical Pharmacology and Therapeutics | 1983 | 74 |
| 27 | The Effect of Sucralfate Pretreatment on the Pharmacokinetics of Ciprofloxacin | Pharmacotherapy | 1989 | 73 |
| 28 | The effect of renal disease on the disposition of venlafaxine | Clinical Pharmacology and Therapeutics | 1994 | 72 |
| 29 | Inactive Prednisone Tablets U.S.P. XVI | Journal of Pharmaceutical Sciences | 1963 | 68 |
| 30 | Pharmacokinetics and pharmacodynamics of methylprednisolone in obesity | Clinical Pharmacology and Therapeutics | 1991 | 65 |
| 31 | A pharmacokinetic perspective on medicament noncompliance | Clinical Pharmacology and Therapeutics | 1993 | 65 |
| 32 | Propoxyphene and norpropoxyphene plasma concentrations in the anephric patient | Clinical Pharmacology and Therapeutics | 1980 | 63 |
| 33 | Serum protein binding of drugs and bilirubin in newborn infants and their mothers | Clinical Pharmacology and Therapeutics | 1980 | 60 |
| 34 | Dose- and time-related effect of troleandomycin on methylprednisolone elimination | Clinical Pharmacology and Therapeutics | 1982 | 58 |
| 35 | Endogenous nitric oxide in expired air: Effects of acute exercise in humans | Life Sciences | 1994 | 58 |
| 36 | Absolute bioavailability of moxifloxacin | Clinical Therapeutics | 1999 | 56 |
| 37 | The Quinolones: An Overview and Comparative Appraisal of Their Pharmacokinetics and Pharmacodynamics | Journal of Clinical Pharmacology | 1988 | 55 |
| 38 | Prednisolone disposition in obese men | Clinical Pharmacology and Therapeutics | 1984 | 53 |
| 39 | Increase in the mediators of asthma in obesity and obesity with type 2 diabetes: Reduction with weight loss | Obesity | 2014 | 52 |
| 40 | Concentration- or effect-controlled clinical trials with sparse data | Clinical Pharmacology and Therapeutics | 1994 | 51 |
| 41 | What are narrow therapeutic index drugs? | Clinical Pharmacology and Therapeutics | 1998 | 50 |
| 42 | A convenient synthesis of chiral N-Boc-amino ethers as potential peptide bond surrogate units | Tetrahedron Letters | 1993 | 49 |
| 43 | Relationship between concentration and anticoagulant effect of heparin in plasma of normal subjects: Magnitude and predictability of interindividual differences* | Clinical Pharmacology and Therapeutics | 1980 | 47 |
| 44 | Noncompartmental Determination of the Steady-State Volume of Distribution During Multiple Dosing | Journal of Pharmaceutical Sciences | 1984 | 44 |
| 45 | Target‐Mediated Drug Disposition Model for Bispecific Antibodies: Properties, Approximation, and Optimal Dosing Strategy | CPT: Pharmacometrics and Systems Pharmacology | 2019 | 43 |
| 46 | The in vitro inhibition of microbial growth and plaque formation by surfactant drugs | Journal of Periodontal Research | 1978 | 42 |
| 47 | An evaluation of population pharmacokinetics in therapeutic trials. Part III. Prospective data collection versus retrospective data assembly | Clinical Pharmacology and Therapeutics | 1989 | 41 |
| 48 | Pharmacokinetics of Capacity‐Limited Systems | Journal of Clinical Pharmacology | 1989 | 41 |
| 49 | Unsuccessful treatment of methicillin-resistant Staphylococcus aureus
endocarditis with dalbavancin | Journal of Clinical Pharmacy and Therapeutics | 2018 | 41 |
| 50 | Prediction of Nephropathy in Type 2 Diabetes: An Analysis of the ACCORD Trial Applying Machine Learning Techniques | Clinical and Translational Science | 2019 | 41 |
